Historique
Bulletin de Périodique
Addiction , Vol.112, n°4 - April 2017
Paru le :
01/04/2017
Article en page(s) :
553-744
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- The Food and Drug Administration and varenicline: should risk communication be improved? [Editorial]. Davies N.M., Thomas K.H., p. 555-558.
- Which cost of alcohol? What should we compare it against? [Addiction debate]. Bhattacharya A., p. 559-565.
- Cost of alcohol: better data will be justified if it is put to better use. Ludbrook A., p. 566.
- Which costs of alcohol do policymakers care about? Angus C., p. 566-568.
- Counting the cost of alcohol: what you measure will shape the policy response. Katikireddi S.V., p. 568-569.
- Counting the costs of alcohol: how useful an aid to policymaking? Sassi F., p. 569-570.
- The political salience of the cost of alcohol should make it a research priority. Bhattacharya A., p. 571.
- 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response [Addiction debate]. Guise A., Albers E.R., Strathdee S.A., p. 572-578.
- Pre-exposure prophylaxis for people who inject drugs and their sex partners. Beyrer C., p. 579-580.
- Improving the effectiveness and delivery of pre-exposure prophylaxis (PrEP) to people who inject drugs. Marshall B.D.L., Milloy M.J., p. 580-582.
- Some PWID communities are ready for PrEP, so what's next? Bruneau J., Roy É., Demers N., Cox J., p. 582-584.
- Pre-exposure prophylaxis (PrEP) for people who inject drugs: reconciling community views and biomedical advances. Guise A., Albers E.R., Strathdee S.A., p. 584-585.
- Alcohol use disorder and divorce: evidence for a genetic correlation in a population-based Swedish sample. Salvatore J.E., Larsson Lönn S., Sundquist J., Lichtenstein P., Sundquist K., Kendler K.S., p. 586-593.
- Commentary on Salvatore et al. (2017): Dyadic research can clarify non-shared environmental influences on alcohol use disorder and divorce. Cranford J.A., p. 594-595.
- Alcohol use among fatally injured victims in São Paulo, Brazil: bridging the gap between research and health services in developing countries. Andreuccetti G., Leyton V., Lemos N.P., Miziara I.D., Ye Y., Takitane J., et al., p. 596-603.
- Alcohol consumption during adolescence is associated with reduced grey matter volumes. Heikkinen N., Niskanen E., Könönen M., Tolmunen T., Kekkonen V., Kivimäki P., et al., p. 604-613.
- Concurrent polysubstance use in a longitudinal study of US youth: associations with sexual orientation. Kecojevic A., Jun H.-J., Reisner S.L., Corliss H.L., p. 614-624.
- Commentary on Kecojevic et al. (2017): Challenges in researching substance use in sexual minority populations. Lea T., p. 625-626.
- Fatal acute poisonings in Australian children (2003-13). Pilgrim J.L., Jenkins E.L., Baber Y., Caldicott D., Drummer O.H., p. 627-639.
- Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands. van der Gouwe D., Brunt T.M., van Laar M., van der Pol P., p. 640-648.
- Commentary van der Gouwe et al. (2017): Drug-testing services and cryptomarkets come of age. Dasgupta N., Gilbert M., p. 649-650.
- Childhood cognitive ability and smoking initiation, relapse and cessation throughout adulthood: evidence from two British cohort studies. Daly M., Egan M., p. 651-659.
- Commentary on Daly & Egan (2017): Intelligence, education and addiction. Cadar D., Kaushal A., p. 660-661.
- Neural mechanisms underlying visual attention to health warnings on branded and plain cigarette packs. Maynard O.M., Brooks J.C.W., Munafò M.R., Leonards U., p. 662-672.
- How do text-messaging smoking cessation interventions confer benefit? A multiple mediation analysis of Text2Quit. Hoeppner B.B., Hoeppner S.S., Abroms L.C., p. 673-682.
- Commentary on Hoeppner et al. (2017): Have we overlooked the importance of feeling cared for in digital smoking cessation interventions? Naughton F., p. 683-684.
- Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes. Subbaraman M.S., Metrik J., Patterson D., Swift R., p. 685-694.
- Testing bidirectional associations among emotion regulation strategies and substance use: a daily diary study. Weiss N.H., Bold K.W., Sullivan T.P., Armeli S., Tennen H., p. 695-704.
- Coverage of alcohol consumption by national surveys in South Africa. Probst C., Shuper P.A., Rehm J., p. 705-710.
- The relationship between gestational age and the severity of neonatal abstinence syndrome. Gibson K.S., Stark S., Kumar D., Bailit J.L., p. 711-716.
- Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome. Mactier H., p. 717-718.
- The potential of neuroimaging for identifying predictors of adolescent alcohol use initiation and misuse. O'Halloran L., Nymberg C., Jollans L., Garavan H., Whelan R., p. 719-726.
- Non-medical use of prescription opioids is associated with heroin initiation among US veterans. Ruan X., Luo J.J., Kaye A.M., Kaye A.D., p. 727-728.
- Reply to Ruan et al. (2017): Non-medical use of prescription opioids is associated with heroin initiation among US veterans. Banerjee G., Edelman E.J., Barry D.T., Becker W.C., Cerdá M., Crystal S., et al., p. 728-729.
- Drug testing in forensic mental health settings. MacCall C.A., p. 729-730.
- Cannabinoid concentrations in Canada's regulated medical cannabis industry. Mammen G., de Freitas L., Rehm J., Rueda S., p. 730-732.
- The Food and Drug Administration and varenicline: should risk communication be improved? [Editorial]. Davies N.M., Thomas K.H., p. 555-558.
- Which cost of alcohol? What should we compare it against? [Addiction debate]. Bhattacharya A., p. 559-565.
- Cost of alcohol: better data will be justified if it is put to better use. Ludbrook A., p. 566.
- Which costs of alcohol do policymakers care about? Angus C., p. 566-568.
- Counting the cost of alcohol: what you measure will shape the policy response. Katikireddi S.V., p. 568-569.
- Counting the costs of alcohol: how useful an aid to policymaking? Sassi F., p. 569-570.
- The political salience of the cost of alcohol should make it a research priority. Bhattacharya A., p. 571.
- 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response [Addiction debate]. Guise A., Albers E.R., Strathdee S.A., p. 572-578.
- Pre-exposure prophylaxis for people who inject drugs and their sex partners. Beyrer C., p. 579-580.
- Improving the effectiveness and delivery of pre-exposure prophylaxis (PrEP) to people who inject drugs. Marshall B.D.L., Milloy M.J., p. 580-582.
- Some PWID communities are ready for PrEP, so what's next? Bruneau J., Roy É., Demers N., Cox J., p. 582-584.
- Pre-exposure prophylaxis (PrEP) for people who inject drugs: reconciling community views and biomedical advances. Guise A., Albers E.R., Strathdee S.A., p. 584-585.
- Alcohol use disorder and divorce: evidence for a genetic correlation in a population-based Swedish sample. Salvatore J.E., Larsson Lönn S., Sundquist J., Lichtenstein P., Sundquist K., Kendler K.S., p. 586-593.
- Commentary on Salvatore et al. (2017): Dyadic research can clarify non-shared environmental influences on alcohol use disorder and divorce. Cranford J.A., p. 594-595.
- Alcohol use among fatally injured victims in São Paulo, Brazil: bridging the gap between research and health services in developing countries. Andreuccetti G., Leyton V., Lemos N.P., Miziara I.D., Ye Y., Takitane J., et al., p. 596-603.
- Alcohol consumption during adolescence is associated with reduced grey matter volumes. Heikkinen N., Niskanen E., Könönen M., Tolmunen T., Kekkonen V., Kivimäki P., et al., p. 604-613.
- Concurrent polysubstance use in a longitudinal study of US youth: associations with sexual orientation. Kecojevic A., Jun H.-J., Reisner S.L., Corliss H.L., p. 614-624.
- Commentary on Kecojevic et al. (2017): Challenges in researching substance use in sexual minority populations. Lea T., p. 625-626.
- Fatal acute poisonings in Australian children (2003-13). Pilgrim J.L., Jenkins E.L., Baber Y., Caldicott D., Drummer O.H., p. 627-639.
- Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands. van der Gouwe D., Brunt T.M., van Laar M., van der Pol P., p. 640-648.
- Commentary van der Gouwe et al. (2017): Drug-testing services and cryptomarkets come of age. Dasgupta N., Gilbert M., p. 649-650.
- Childhood cognitive ability and smoking initiation, relapse and cessation throughout adulthood: evidence from two British cohort studies. Daly M., Egan M., p. 651-659.
- Commentary on Daly & Egan (2017): Intelligence, education and addiction. Cadar D., Kaushal A., p. 660-661.
- Neural mechanisms underlying visual attention to health warnings on branded and plain cigarette packs. Maynard O.M., Brooks J.C.W., Munafò M.R., Leonards U., p. 662-672.
- How do text-messaging smoking cessation interventions confer benefit? A multiple mediation analysis of Text2Quit. Hoeppner B.B., Hoeppner S.S., Abroms L.C., p. 673-682.
- Commentary on Hoeppner et al. (2017): Have we overlooked the importance of feeling cared for in digital smoking cessation interventions? Naughton F., p. 683-684.
- Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes. Subbaraman M.S., Metrik J., Patterson D., Swift R., p. 685-694.
- Testing bidirectional associations among emotion regulation strategies and substance use: a daily diary study. Weiss N.H., Bold K.W., Sullivan T.P., Armeli S., Tennen H., p. 695-704.
- Coverage of alcohol consumption by national surveys in South Africa. Probst C., Shuper P.A., Rehm J., p. 705-710.
- The relationship between gestational age and the severity of neonatal abstinence syndrome. Gibson K.S., Stark S., Kumar D., Bailit J.L., p. 711-716.
- Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome. Mactier H., p. 717-718.
- The potential of neuroimaging for identifying predictors of adolescent alcohol use initiation and misuse. O'Halloran L., Nymberg C., Jollans L., Garavan H., Whelan R., p. 719-726.
- Non-medical use of prescription opioids is associated with heroin initiation among US veterans. Ruan X., Luo J.J., Kaye A.M., Kaye A.D., p. 727-728.
- Reply to Ruan et al. (2017): Non-medical use of prescription opioids is associated with heroin initiation among US veterans. Banerjee G., Edelman E.J., Barry D.T., Becker W.C., Cerdá M., Crystal S., et al., p. 728-729.
- Drug testing in forensic mental health settings. MacCall C.A., p. 729-730.
- Cannabinoid concentrations in Canada's regulated medical cannabis industry. Mammen G., de Freitas L., Rehm J., Rueda S., p. 730-732.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
This paper explores and develops issues raised by recent debates about the cost of alcohol to England and Wales. It advances two arguments. First, that the commonly used estimates for alcohol harm in England and Wales are outdated, not fully rel[...]
!['PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response [Addiction debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_78728.webp)
A. GUISE ;
E. R. ALBERS ;
S. A. STRATHDEE
|
2017
Dans Addiction (Vol.112, n°4, April 2017) Article : Périodique
Dans Addiction (Vol.112, n°4, April 2017) Article : Périodique
Background and aims: Pre-exposure prophylaxis for HIV, or 'PrEP', is the use of antiretroviral medicines by people who are HIV-negative to protect themselves against acquiring HIV. PrEP has shown efficacy for preventing HIV acquisition. Despite [...]
D. VAN DER GOUWE ;
T. M. BRUNT ;
M. VAN LAAR ;
P. VAN DER POL
|
2017
Dans Addiction (Vol.112, n°4, April 2017) Article : Périodique
Dans Addiction (Vol.112, n°4, April 2017) Article : Périodique
Background and aims: On-line drug markets flourish and consumers have high expectations of on-line quality and drug value. The aim of this study was to (i) describe on-line drug purchases and (ii) compare on-line with off-line purchased drugs re[...]